Deep Track Capital’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NBIX
Deep Track Capital's NBIX Position: Q3 2026 in Review
Deep Track Capital opened a new position in Neurocrine Biosciences (NBIX) in Q3 2026: 200,000 shares worth $28.4M. The stake represents 0.46% of the portfolio and ranks #50 among its holdings. This is a return to the name: Deep Track Capital previously reported a position in NBIX as recently as Q3 2023.
Deep Track Capital first reported a position in NBIX in Q3 2023 and has held it in 2 quarters since. The position peaked at $33.8M in Q3 2023. 766 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.
- Deep Track Capital held 200,000 shares of Neurocrine Biosciences worth $28.4M as of Q3 2026.
- Neurocrine Biosciences was a new Deep Track Capital position in Q3 2026.
- Neurocrine Biosciences made up 0.46% of Deep Track Capital's portfolio in Q3 2026, its #50 holding.
- Deep Track Capital first reported a position in Neurocrine Biosciences in Q3 2023 and has held it in 2 quarters since.
- Deep Track Capital's Neurocrine Biosciences position peaked at $33.8M in Q3 2023.
- 766 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.
Based on Deep Track Capital's 13F filing for Q3 2026, filed 16 Nov 2026.